Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis

Oncotarget
Rebecca A SagerGennady Bratslavsky

Abstract

Birt-Hogg-Dubé (BHD) is an autosomal dominant genetic syndrome caused by germline mutations in the FLCN gene that predisposes patients to develop renal tumors. Renal angiomyolipoma (AML) is not a renal tumor sub-type associated with BHD. AML is, however, a common phenotypic manifestation of Tuberous Sclerosis Complex (TSC) syndrome caused by mutations in either the TSC1 or TSC2 tumor suppressor genes. Previous case reports of renal AML in patients with BHD have speculated on the molecular and clinical overlap of these two syndromes as a result of described involvement of the gene products in the mTOR pathway. Our recent work provided a new molecular link between these two syndromes by identifying FLCN and Tsc2 as clients of the molecular chaperone Hsp90. Folliculin interacting proteins FNIP1/2 and Tsc1 are important for FLCN and Tsc2 stability as new Hsp90 co-chaperones. Here we present a case of sporadic AML as a result of somatic Tsc1/2 loss in a patient with BHD. We further demonstrate that FNIP1 and Tsc1 are capable of compensating for each other in the chaperoning of mutated FLCN tumor suppressor. Our findings demonstrate interconnectivity and compensatory mechanisms between the BHD and TSC pathways.

References

Dec 31, 1993·Cell·UNKNOWN European Chromosome 16 Tuberous Sclerosis Consortium
Aug 8, 1997·Science·M van SlegtenhorstD J Kwiatkowski
Dec 2, 2000·Journal of the American Academy of Dermatology·V LiuE H Page
Sep 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrew R TeeJohn Blenis
Dec 3, 2002·The American Journal of Surgical Pathology·Christian P PavlovichMaria J Merino
Apr 12, 2005·The Journal of Urology·Christian P PavlovichW Marston Linehan
Apr 27, 2005·American Journal of Human Genetics·Laura S SchmidtW Marston Linehan
Jul 16, 2005·Journal of the American Academy of Dermatology·Julie V SchafferIsrael Dvoretzky
Feb 9, 2006·The Journal of Biological Chemistry·Huira Chong-KoperaKun-Liang Guan
Oct 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Masaya BabaBerton Zbar
Feb 7, 2009·Clinical and Experimental Dermatology·N Misago, Y Narisawa
Oct 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yukiko HasumiW Marston Linehan
Jan 18, 2011·The Journal of Urology·Ari AdamyPaul Russo
Jun 13, 2012·Internal Medicine·Kazunori Tobino, Kuniaki Seyama
Oct 12, 2012·Hereditary Cancer in Clinical Practice·Noralane M LindorMark Pittelkow
Feb 7, 2013·European Journal of Human Genetics : EJHG·Laura Maria PradellaGiuseppe Gasparre
Sep 4, 2015·Nature Reviews. Urology·Laura S Schmidt, W Marston Linehan
May 27, 2016·Nature Reviews. Disease Primers·Elizabeth P HenskeElizabeth A Thiele
Jun 30, 2016·Nature Communications·Mark R WoodfordMehdi Mollapour
Sep 20, 2016·American Journal of Medical Genetics. Part a·Eryn Dow, Ingrid Winship
Apr 22, 2017·Nature Reviews. Molecular Cell Biology·Florian H SchopfJohannes Buchner
Sep 12, 2017·Molecular Cell·Priyanka SahasrabudheJohannes Buchner

❮ Previous
Next ❯

Citations

Mar 1, 2019·Scientific Reports·Matthildi ValianouAristotelis Astrinidis
Nov 3, 2020·PLoS Genetics·Lene ClausenRasmus Hartmann-Petersen

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
ubiquitination
biopsy
transfection

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.